BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31231571)

  • 1. How I treat cancers of unknown primary.
    Zarkavelis G; Mauri D; Pentheroudakis G
    ESMO Open; 2019; 4(Suppl 2):e000502. PubMed ID: 31231571
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer of unknown primary (CUP): does cause of death and family history implicate hidden phenotypically changed primaries?
    Hemminki K; Bevier M; Sundquist J; Hemminki A
    Ann Oncol; 2012 Oct; 23(10):2720-2724. PubMed ID: 22473595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location of metastases in cancer of unknown primary are not random and signal familial clustering.
    Hemminki K; Sundquist K; Sundquist J; Hemminki A; Ji J
    Sci Rep; 2016 Mar; 6():22891. PubMed ID: 26956545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second primary cancers after cancer of unknown primary in Sweden and Germany: efficacy of the modern work-up.
    Liu H; Hemminki K; Sundquist J; Holleczek B; Katalinic A; Emrich K; Brenner H;
    Eur J Cancer Prev; 2013 May; 22(3):210-4. PubMed ID: 22960777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The currently declining incidence of cancer of unknown primary.
    Rassy E; Pavlidis N
    Cancer Epidemiol; 2019 Aug; 61():139-141. PubMed ID: 31254795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Risk in Patients With Carcinoma of Unknown Primary.
    Samadder NJ; Smith KR; Hanson H; Pimentel R; Wong J; Boucher K; Akerley W; Gilcrease G; Ulrich CM; Burt RW; Curtin K
    JAMA Oncol; 2016 Mar; 2(3):340-6. PubMed ID: 26863281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant pleural effusion and cancer of unknown primary site: a review of literature.
    Awadallah SF; Bowling MR; Sharma N; Mohan A
    Ann Transl Med; 2019 Aug; 7(15):353. PubMed ID: 31516899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of cancer of unknown primary site: a national survey of Australian medical oncologists.
    Karapetis CS; Guccione L; Tattersall MH; Gooden H; Vajdic CM; Lambert S; Robotin M; Mileshkin L; Schofield P
    Intern Med J; 2017 Apr; 47(4):408-414. PubMed ID: 28101916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy: a new diagnostic, predictive and prognostic window in cancers of unknown primary.
    El Rassy E; Khaled H; Pavlidis N
    Eur J Cancer; 2018 Dec; 105():28-32. PubMed ID: 30388661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time trends in survival from cancer of unknown primary: small steps forward.
    Riihimäki M; Hemminki A; Sundquist K; Hemminki K
    Eur J Cancer; 2013 Jul; 49(10):2403-10. PubMed ID: 23518210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric manifestations, personality traits and health-related quality of life in cancer of unknown primary site.
    Hyphantis T; Papadimitriou I; Petrakis D; Fountzilas G; Repana D; Assimakopoulos K; Carvalho AF; Pavlidis N
    Psychooncology; 2013 Sep; 22(9):2009-15. PubMed ID: 23359412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does Cancer of Unknown Primary (CUP) Truly Exist as a Distinct Cancer Entity?
    Bochtler T; Krämer A
    Front Oncol; 2019; 9():402. PubMed ID: 31165045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health service utilisation and investigations before diagnosis of cancer of unknown primary (CUP): A population-based nested case-control study in Australian Government Department of Veterans' Affairs clients.
    Vajdic CM; Schaffer AL; Dobbins TA; Ward RL; Er CC; Pearson SA
    Cancer Epidemiol; 2015 Aug; 39(4):585-92. PubMed ID: 26088263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer of Unknown Primary: A Review on Clinical Guidelines in the Development and Targeted Management of Patients with the Unknown Primary Site.
    Qaseem A; Usman N; Jayaraj JS; Janapala RN; Kashif T
    Cureus; 2019 Sep; 11(9):e5552. PubMed ID: 31695975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin.
    Vikeså J; Møller AK; Kaczkowski B; Borup R; Winther O; Henao R; Krogh A; Perell K; Jensen F; Daugaard G; Nielsen FC
    BMC Cancer; 2015 Mar; 15():151. PubMed ID: 25885340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy.
    Gatalica Z; Xiu J; Swensen J; Vranic S
    Eur J Cancer; 2018 May; 94():179-186. PubMed ID: 29571084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010.
    Brewster DH; Lang J; Bhatti LA; Thomson CS; Oien KA
    Cancer Epidemiol; 2014 Jun; 38(3):227-34. PubMed ID: 24726751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and immune profiling for cancer of unknown primary site.
    Haratani K; Hayashi H; Takahama T; Nakamura Y; Tomida S; Yoshida T; Chiba Y; Sawada T; Sakai K; Fujita Y; Togashi Y; Tanizaki J; Kawakami H; Ito A; Nishio K; Nakagawa K
    J Immunother Cancer; 2019 Sep; 7(1):251. PubMed ID: 31519206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma of unknown primary with a colon-cancer profile-changing paradigm and emerging definitions.
    Varadhachary GR; Raber MN; Matamoros A; Abbruzzese JL
    Lancet Oncol; 2008 Jun; 9(6):596-9. PubMed ID: 18510991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer of unknown primary is associated with diabetes.
    Hemminki K; Försti A; Sundquist K; Li X
    Eur J Cancer Prev; 2016 May; 25(3):246-51. PubMed ID: 26011105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.